Last year, the Federal Trade Commission (FTC) challenged what it called "junk patent listings" by several pharmaceutical companies, including Novo Nordisk for its patent listing for Ozempic, Saxenda, and Victoza
The Takeaway Semaglutide and other GLP-1 drugs are associated with a wide variety of adverse events, most commonly gastrointestinal distress
SeekPeptides members often find that connecting with others who have navigated the same adjustment period provides invaluable perspective
[PMID 27797785] Lipase increases In trials, lipase increases occurred in 5.3% of Saxenda-treated patients and 2.2% of placebo-treated patients, with levels 3 X ULN occurring in 2.1% and 1%, respectively
Ethics statement The studies involving humans were approved by Institutional Review Board of the First Affiliated Hospital of Soochow University
Important information This product is a compounded preparation and has not been evaluated or approved by the FDA